(Q60685892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

main subject

phase I clinical trial

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Michael Jefford

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

11

Zalcberg JR

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Michael M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Biagi J

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Foo KF

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ngan SY

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Leong T

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hui A

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Milner AD

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Thomas RJ

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

20 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

123-129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

A comparison of multimodal therapy and surgery for esophageal adenocarcinoma

20 December 2019

cites work

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

1 reference

12 December 2020

Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice

1 reference

12 December 2020

Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study

1 reference

12 December 2020

1 reference

12 December 2020

Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor

1 reference

12 December 2020

Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group

1 reference

12 December 2020

Barrett's oesophagus, oesophageal cancer and colon cancer: an explanation of the association and cancer chemopreventive potential of non-steroidal anti-inflammatory drugs

1 reference

12 December 2020

Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma

1 reference

12 December 2020

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

1 reference

12 December 2020

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival

1 reference

12 December 2020

Enhancing Radiotherapy With Cyclooxygenase-2 Enzyme Inhibitors: A Rational Advance?

1 reference

12 December 2020

Cisplatin, fluorouracil, celecoxib, and RT in resectable esophageal cancer: preliminary results.

1 reference

12 December 2020

Why cyclooxygenase-2 inhibition plus chemotherapy?

1 reference

12 December 2020

The role of cyclooxygenases in inflammation, cancer, and development

1 reference

12 December 2020

Intratumoral COX-2 gene expression is a predictive factor for colorectal cancer response to fluoropyrimidine-based chemotherapy

1 reference

12 December 2020

Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus

1 reference

12 December 2020

Cyclooxygenase-2 inhibition and renal physiology

1 reference

12 December 2020

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

12 December 2020

Multimodality therapy for esophageal cancer

1 reference

12 December 2020

Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells

1 reference

12 December 2020

Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?

1 reference

12 December 2020

Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme

1 reference

12 December 2020

Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.

1 reference

12 December 2020

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

12 December 2020

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

1 reference

12 December 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

12 December 2020

Cyclooxygenase-2 expression in human esophageal carcinoma

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

10.1007/S10637-006-9016-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17053988%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference